title: Donor activating KIR2DS1 in leukemia.
authors.affiliation: University of California, San Francisco, San Francisco, CA.
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Venstrom
authors.forename: Bo
authors.initials: B
authors.lastname: Dupont
authors.forename: Katharine C
authors.initials: KC
authors.lastname: Hsu
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Pittari
authors.forename: Ted A
authors.initials: TA
authors.lastname: Gooley
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Chewning
authors.forename: Stephen
authors.initials: S
authors.lastname: Spellman
authors.forename: Michael
authors.initials: M
authors.lastname: Haagenson
authors.forename: Meighan M
authors.initials: MM
authors.lastname: Gallagher
authors.forename: Mari
authors.initials: M
authors.lastname: Malkki
authors.forename: Effie
authors.initials: E
authors.lastname: Petersdorf
mesh_terms: D015236:HLA-C Antigens / Q000235:genetics*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000517:prevention & control*; D054340:Receptors, KIR / Q000235:genetics*
chemical_list: D015236:HLA-C Antigens; D054340:Receptors, KIR